ALDX Operating Cash Flow (Statement)
Aldeyra Therapeutics Inc · Operating Cash Flow (Statement)
ALDX Operating Cash Flow (Statement)
Latest reported-$22.02Mperiod ending
ALDX TTM Cash from Operations (-$1.71M → -$22.02M)
TTM operating cash flow (statement)
High-resolution chart · PNG
ALDX operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -22,020,272 | |
| -25,986,072 | |
| -33,345,682 | |
| -40,083,182 | |
| -41,036,683 | |
| -45,705,759 | |
| -43,208,747 | |
| -30,671,462 | |
| -30,721,459 | |
| -30,854,997 | |
| -30,326,128 | |
| -42,057,745 | |
| -46,607,049 | |
| -53,207,806 | |
| -56,637,187 | |
| -56,983,709 | |
| -52,843,591 | |
| -41,957,365 | |
| -42,555,907 | |
| -39,295,405 | |
| -37,098,757 | |
| -35,605,444 | |
| -37,493,455 | |
| -40,402,581 | |
| -42,480,175 | |
| -47,712,000 | |
| -44,984,226 | |
| -41,726,078 | |
| -41,099,704 | |
| -34,534,516 | |
| -29,857,131 | |
| -26,907,473 | |
| -23,924,405 | |
| -22,990,612 | |
| -19,222,862 | |
| -18,113,807 | |
| -16,911,771 | |
| -14,852,997 | |
| -15,147,512 | |
| -14,221,175 | |
| -13,600,545 | |
| -11,949,247 | |
| -9,311,753 | |
| -7,935,507 | |
| -6,263,338 | |
| -5,555,966 | |
| -4,775,994 | |
| -3,770,264 | |
| -3,076,181 | |
| -2,472,472 | |
| -1,706,601 | |
| -1,265,852 |